TBX3 and TBX5 duplication: A family with an atypical overlapping Holt-Oram/ulnar-mammary syndrome phenotype.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 30 03 2020
revised: 15 01 2021
accepted: 25 03 2021
pubmed: 1 5 2021
medline: 11 8 2021
entrez: 30 4 2021
Statut: ppublish

Résumé

Holt-Oram syndrome (HOS) is a rare, autosomal dominant heart-hand syndrome caused by mutations in the TBX5 gene. A wide spectrum of TBX5 mutations have been reported previously, most resulting in a null allele leading to haploinsufficiency. TBX5 gene duplications have been previously reported in association with typical and atypical HOS phenotypes. Ulnar-Mammary syndrome (UMS) is a distinct rare, autosomal dominant condition caused by mutations in the TBX3 gene. TBX5 and TBX3 are physically linked in cis on human chromosome 12 and contiguous chromosome 12q24 deletions comprising both TBX5 and TBX3 genes have been previously reported but to our knowledge, duplications have never been described. We report on a large German family with at least 17 affected individuals over 6 generations bearing a duplication at 12q24.21 identified on array-CGH comprising both TBX5 and TBX3 genes. Affected patients are presenting with HOS and UMS symptoms, consisting of variable limb anomalies involving the radial and the ulnar rays and cardiac findings such as congenital heart defects, persistent arterial duct or aortic stenosis, and non-classical symptoms, such as supernumerary nipples and cardiomyopathy. Fluorescence in situ hybridisation confirmed a tandem duplication at the 12q24.21 locus. This is the first report of a contiguous TBX3/TBX5 duplication associated with HOS/UMS phenotype.

Identifiants

pubmed: 33930582
pii: S1769-7212(21)00079-3
doi: 10.1016/j.ejmg.2021.104213
pii:
doi:

Substances chimiques

T-Box Domain Proteins 0
T-box transcription factor 5 0
TBX3 protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104213

Subventions

Organisme : Medical Research Council
ID : MC_PC_13052
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U117560477
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S000038/1
Pays : United Kingdom

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

Camille Cenni (C)

Department of Clinical Genetics, Guy's Hospital, London, UK.

Stephanie Andres (S)

Institute of Human Genetics, Technische Universitat Munchen, Munich, Germany.

Maja Hempel (M)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Tim M Strom (TM)

Institute of Human Genetics, Technische Universitat Munchen, Munich, Germany.

Ellen Thomas (E)

Genomics England, Queen Mary University of London, London, UK; Genomic Medicine, Imperial College Healthcare NHS Trust, London, UK.

Angela Davies (A)

Genetics Laboratories. Guy's Hospital, London, UK.

Norma Timoney (N)

Department of Plastic Surgery, St Thomas Hospital, London, UK.

Alessandra Frigiola (A)

Department of Cardiology, St Thomas Hospital, London, UK.

Malcolm Logan (M)

Randall Centre for Cell and Molecular Biophysics, King's College London, Guy's Campus, London, UK.

Muriel Holder-Espinasse (M)

Department of Clinical Genetics, Guy's Hospital, London, UK. Electronic address: muriel.holder@gstt.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH